Cost-effectiveness of infliximab (Remicade) in Sweden

被引：0
|
作者：
Kobelt, G
Jonsson, L
Lindquist, E
Eberhardt, K
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
631
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of acarbose for the management of impaired glucose tolerance in Sweden
    Quilici, S
    MacLaine, G
    Hutka, M
    Chancellor, J
    McGuire, A
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 741 - 742
  • [42] The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden
    P. Lindgren
    B. Jönsson
    J. DuChane
    [J]. The European Journal of Health Economics, 2003, 4 (1) : 37 - 42
  • [43] Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
    Granstrom, Ola
    Bergenheim, Klas
    McEwan, Phil
    Sennfalt, Karin
    Henriksson, Martin
    [J]. PRIMARY CARE DIABETES, 2012, 6 (02) : 127 - 136
  • [44] Cost-effectiveness analysis of hepatitis B vaccination to children in Sweden
    Wolff, Ellen
    Larsson, S.
    Wahl, H. Fues
    Roth, A.
    Axelsson, M.
    Berglund, T.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26
  • [45] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN SWEDEN
    Thurston, S.
    Webb, C.
    Borgman, B.
    Van Hout, B.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A166 - A167
  • [46] Reorganization of diagnostic imaging in south Sweden: Realization and cost-effectiveness
    Pettersson, H
    [J]. ACADEMIC RADIOLOGY, 1998, 5 : S315 - S316
  • [47] Intact Cost-effectiveness of Screening for Abdominal Aortic Aneurysms in Sweden
    Sogaard, R.
    Lindholt, J. S.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 47 (04) : 366 - 366
  • [48] The cost-effectiveness of risperidone long-acting injectable in Sweden
    Damen, J.
    Heeg, B. M. S.
    Lothgren, M.
    Van Hout, B. A.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A293 - A294
  • [49] COST-EFFECTIVENESS OF BAZEDOXIFENE IN THE UK AND SWEDEN INCORPORATING THE FRAX®-ALGORITHM
    Strom, O.
    Coelho, J.
    Borgstrom, F.
    Mccloskey, E.
    Oden, A.
    Johansson, H.
    Kanis, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 13 - 13
  • [50] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN SECONDARY PREVENTION OF ACS IN SWEDEN
    Begum, N.
    Van Hout, B.
    Thurston, S.
    Schoeman, O.
    Fraschke, A.
    Verheugt, F. W. A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A524 - A524
12345